-
Signature
-
/s/ Kristie Scott, Attorney-in-Fact
-
Issuer symbol
-
XMTR
-
Transactions as of
-
02 Jan 2026
-
Net transactions value
-
-$449,522
-
Form type
-
4
-
Filing time
-
06 Jan 2026, 16:50:52 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Miln James |
Chief Financial Officer |
C/O XOMETRY, INC., 6116 EXECUTIVE BLVD, SUITE 800, NORTH BETHESDA |
/s/ Kristie Scott, Attorney-in-Fact |
06 Jan 2026 |
0001786790 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
XMTR |
Class A Common Stock |
Sale |
$11,436 |
-188 |
-0.13% |
$60.83 |
141,010 |
02 Jan 2026 |
Direct |
F1, F2 |
| transaction |
XMTR |
Class A Common Stock |
Sale |
$25,519 |
-410 |
-0.29% |
$62.24 |
140,600 |
02 Jan 2026 |
Direct |
F1, F3 |
| transaction |
XMTR |
Class A Common Stock |
Sale |
$28,826 |
-455 |
-0.32% |
$63.35 |
140,145 |
05 Jan 2026 |
Direct |
F1, F4, F5 |
| transaction |
XMTR |
Class A Common Stock |
Sale |
$25,465 |
-397 |
-0.28% |
$64.14 |
139,748 |
05 Jan 2026 |
Direct |
F1, F4, F6 |
| transaction |
XMTR |
Class A Common Stock |
Sale |
$41,783 |
-633 |
-0.45% |
$66.01 |
139,115 |
05 Jan 2026 |
Direct |
F1, F4, F7 |
| transaction |
XMTR |
Class A Common Stock |
Sale |
$241,151 |
-3,605 |
-2.6% |
$66.89 |
135,510 |
05 Jan 2026 |
Direct |
F1, F4, F8 |
| transaction |
XMTR |
Class A Common Stock |
Sale |
$75,342 |
-1,113 |
-0.82% |
$67.69 |
134,397 |
05 Jan 2026 |
Direct |
F1, F4, F9 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: